Analyst Ratings for Rexahn Pharmaceuticals, Inc. (REXN)
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 8/8/2019 | IFS Securities | David Bouchey | Downgrade | Market Perform (Strong Buy) |
5.00 (48.00) |
4.93 (1.81) |
-63.29% | Details |
| 8/7/2019 | H.C. Wainwright | Joseph Pantginis | Downgrade | Neutral (Buy) |
3.00 (N/A) |
21.19 (1.81) |
-91.46% | Details |
